SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)
SS Innovations International (SSII) posted Cash from Investing Activities of -$54189.0 for Q1 2026, up 96.84% sequentially from -$1.7 million in Q4 2025, and up 93.79% YoY from -$27962.5 in Q1 2025.
SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026) Analysis & Trends
SS Innovations International has reported Cash from Investing Activities for 10 years, with the latest figure at -$54189.0 in Q1 2026.
- Quarterly Cash from Investing Activities rose 93.79% year-over-year to -$54189.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 101.88% YoY) and the FY2025 annual result came in at -$3.7 million, down 453.16% from the prior year.
- Cash from Investing Activities grew to -$54189.0 in Q1 2026 per SSII's latest filing, from -$1.7 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $1.7 million in Q3 2024 and troughed at -$2.1 million in Q2 2024.
- A 5-year average of -$331267.5 and a median of -$127255.0 in 2024 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 6329.8% in 2023, then soared 872.1% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$137530.0 in 2022, then advanced by 7.48% to -$127249.0 in 2023, then increased by 1.66% to -$125142.0 in 2024, then plunged by 1270.07% to -$1.7 million in 2025, then soared by 96.84% to -$54189.0 in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$54189.0, -$1.7 million, and -$755075.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | SS Innovations International | 731.50 Mn | 709.20 Mn | 7.10 Mn | -160,871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -160,871.00 |
| Jun 30, 2026 | -160,871.00 |
| Mar 31, 2026 | -54,189.00 |
| Mar 31, 2026 | -54,189.00 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -755,075.00 |
| Sep 30, 2025 | -755,075.00 |
| Jun 30, 2025 | -316,648.00 |
| Jun 30, 2025 | -316,648.00 |
| Mar 31, 2025 | -872,804.00 |
| Mar 31, 2025 | -872,804.00 |
| Dec 31, 2024 | -125,142.00 |
| Dec 31, 2024 | -125,142.00 |
| Sep 30, 2024 | 1.70 Mn |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -127,255.00 |
| Mar 31, 2024 | -127,255.00 |